MRC-Holland MLPA. Description version 07; 11 AUG 2015

Size: px
Start display at page:

Download "MRC-Holland MLPA. Description version 07; 11 AUG 2015"

Transcription

1 mix P347-A2 Hemochromatosis Lot A As compared to version A1 (lot A1-1109), four reference s have been replaced and the control fragments have been adjusted (QDX2). Hereditary hemochromatosis (HH) is an inherited disorder characterised by progressive iron deposition and tissue injury in multiple organs. HH has been demonstrated to result from mutations in several genes involved in the regulation of iron homeostasis such as HFE, TFR2, HFE2, HAMP and SLC40A1. Mutations in these genes act in an autosomal recessive manner except for SLC40A1 that manifest in autosomal dominant phenotypes. The most common form of HH is associated with the homozygous C282Y mutation of the HFE gene (Alexander et al., 2009). The HFE gene comprises 6 exons, spanning about 8 kb of genomic DNA on 6p22.2, 26 Mb from the p- telomere. The SLC40A1 gene contains 8 exons, spanning 20 kb and is located on chromosome 2q32.2, 190 Mb from the p-telomere. The TFR2 gene consists of 18 exons and has a length of approximately 21 kb on chromosome 7q22.1, 100 Mb from the p-telomere. The HFE2 gene comprises 4 exons, spanning about 4 kb of genomic DNA on 1q21.1, 145 Mb from the p- telomere. The HAMP gene contains 3 exons, spanning 3 kb and is located on chromosome 19q13.12, 36 Mb from the p-telomere. The P347-A2 mix contains s for each exon of the HFE, SLC40A1 and HAMP genes. For the HFE2 gene 3 s have been included and for the TFR2 gene 8 s are present. Furthermore, mutationspecific s for the HFE C282Y mutation and HAMP G71D mutation detecting the wild-type sequence are present. Finally, 11 reference s are included, which detect sequences on various autosomal chromosomes. This SALSA mix is designed to detect deletions/duplications of one or more sequences in the aforementioned genes and to detect the presence of the aforementioned mentioned point mutation in a DNA sample. Heterozygous deletions of recognition sequences should give a 35-50% reduced relative peak area of the amplification product of that. Note that a mutation or polymorphism in the sequence detected by a can also cause a reduction in relative peak area, even when not located exactly on the ligation site! In addition, some signals are more sensitive to sample purity and small changes in experimental conditions. Therefore, deletions and duplications detected by MLPA should always be confirmed by other methods. Not all deletions and duplications detected by MLPA will be pathogenic; users should always verify the latest scientific literature when interpreting their findings. We have no information on what percentage of defects in these genes is caused by deletions/duplications of complete exons. Finally, note that most defects in this gene are expected to be small (point) mutations which will not be detected by this SALSA MLPA test. SALSA mixes and reagents are sold by for research purposes and to demonstrate the possibilities of the MLPA technique. They are not CE/FDA certified for use in diagnostic procedures. Purchase of the test mixes and reagents includes a limited license to use these products for research purposes. The use of this SALSA mix and reagents requires a thermocycler with heated lid and sequence type electrophoresis equipment. Different fluorescent PCR primers are available. The MLPA technique has been first described in Nucleic Acid Research 30, e57 (2002). More information Website : info@mlpa.com (information & technical questions); order@mlpa.com (for orders) Mail : bv; Willem Schoutenstraat 6, 1057 DN Amsterdam, the Netherlands SALSA mix P347 Hemochromatosis Page 1 of 7

2 Data analysis The P347-A2 Hemochromatosis mix contains 45 MLPA s with amplification products between 136 and 481 nt. This includes one specific for the HFE C282Y mutation, which will only generate a signal when the mutation is present and one detecting the wild-type sequence of the HAMP G71D mutation. In addition, it contains 9 control fragments generating an amplification product smaller than 120 nt: four DNA Quantity fragments (Q-fragments) at nt, three DNA denaturation control fragments (Dfragments) at nt, one X-fragment at 100 nt and one Y-fragment at 105 nt. More information on how to interpret observations on these control fragments can be found in the MLPA protocol. Data generated by this mix can first be normalised intra-sample by dividing the peak area of each s amplification product by the total area of only the reference s in this mix (block normalisation). Secondly, inter-sample normalisation can be achieved by dividing the intra-normalised ratio in a sample by the average intra-normalised ratio of all reference samples. Please note that this type of normalisation assumes no changes occurred in the genomic regions recognised by the reference s. Data normalisation should be performed within one experiment. Only samples purified by the same method should be compared. Confirmation of most exons deletions and amplifications can be done by e.g. QFPCR, FISH, Southern blots or long range PCR. Note that Coffalyser, the MLPA analysis tool developed at, can be downloaded free of charge from our website This mix was developed by R. Vijzelaar at. In case the results obtained with this mix lead to a scientific publication, it would be very much appreciated if the mix designer could be made a co-author. Info/remarks/suggestions for improvement: info@mlpa.com. SALSA mix P347 Hemochromatosis Page 2 of 7

3 Table 1. P347-A2 Hemochromatosis mix Chromosomal position Reference HFE SLC40A1 TFR2 HFE2 HAMP Q-fragments: DNA quantity; only visible with less than 100 ng sample DNA D-fragments: Low signal of 88 or 96 nt fragment indicates incomplete denaturation 100 X-fragment: Specific for the X chromosome 105 Y-fragment: Specific for the Y chromosome 136 Reference L q SLC40A L HFE L b 154 SLC40A L HFE L Reference L q Ж SLC40A SP0151-L HFE L SLC40A L TFR L * Reference L q Ж HFE SP0152-L SLC40A L HFE L TFR L Ж SLC40A SP0153-L Reference L q HFE L a 250 Ж HAMP SP0154-L HFE L TFR L b 274 Ж HFE SP0155-L Reference L q HAMP L / G71D WT 301 HFE L TFR L SLC40A L TFR L Reference L p HFE L Ж HAMP SP0156-L Ж HFE SP0157-L TFR L HFE L * Reference L q * Reference L q Ж ± HFE SP0158-L16030 C282Y mutation 419 HFE L a 427 SLC40A L Ж HAMP SP0159-L * Reference L q TFR L Reference L q TFR L Reference L q26 * New in version A2 (from lot A onwards). Changed from lot A onwards. Small change in length, no change in sequence detected. Ж This consists of three parts and has two ligation sites. ± Mutation-specific. This has been tested on patient samples and will only generate a signal when the C282Y mutation is present. Wild type sequence detected. The presence of the G71D mutation will result in a decreased signal. SALSA mix P347 Hemochromatosis Page 3 of 7

4 Note: numbering might be different as compared to literature! Please notify us of any mistakes. The identity of the genes detected by the reference s is available on request: info@mlpa.com. Table 2. P347 s arranged according to chromosomal location Table 2a. HFE gene HFE NM_ next start codon (ex 1) 208 Ж SP nt before ex 1; GTGTTTCACAAG-33nt spanning oligo 1 L AAGTTCTGAAAG 3.6 kb L a 23 nt before ex 2a CTACACATGGTT-AAGGCCTGTTGC 0.1 kb L a GACCTTGGTCTT-TCCTTGTTTGAA 0.4 kb L nt before ex 3 GGGATTTTTCCA-GAGTCCCACACC 0.1 kb L GACCACCTTGAA-TTCTGCCCTGAC 1.3 kb L a 2 nt before ex 4a TCTTTCCTGTCA-AGTGCCTCCTTT 0.2 kb 409 Ж ± SP0158-4a ; GAGATATACGTA-25nt spanning oligo L16030 C282Y CAGCCCCTCATT 0.2 kb L TTAGAGCCCTCA-CCGTCTGGCACC 0.1 kb L TTGTTCATTGGA-ATTTTGTTCATA 1.2 kb 274 Ж SP ; AACTCCTTGATT-36nt spanning oligo 6 L CCATTTAGGTTT 0.1 kb 364 Ж SP ; TGTCTCTCATGA-28nt spanning oligo 6 L CATTTCCTCCGT stop codon (ex 6) ± Mutation-specific. This has been tested on patient samples and will only generate a signal when the C282Y mutation is present. Ж This consists of three parts and has two ligation sites. The NM_ sequence represents transcript variant 1 and is a reference standard in the NCBI RefSeqGene project. Table 2b. SLC40A1 gene SLC40A1 NM_ next start codon (ex 1) L TCCTGTTAACAA-GCACCTCAGCGA 0.7 kb L CTTGGCCGACTA-CCTGACCTCTGC 4.6 kb L TGGCACTTTGCG-GTGTCTGTGTTT 2.4 kb L TCGCTGGTGGTA-CAGAATGTTTCA 1.2 kb 172 Ж SP ; ACTGCTACTGCA-36nt spanning oligo 5 L GGAGAAGACAGA 6.2 kb L GATTGACCAGTT-AACCAACATCTT 1.7 kb L ACAGCTTTCCTG-TTTGATCTTGTG 1.8 kb 233 Ж SP ; TGATCTTCTGCA-30nt spanning oligo 8 L TGAAGCTTTTGG stop codon (ex 8) Ж This consists of three parts and has two ligation sites. The NM_ sequence is a reference standard in the NCBI RefSeqGene project. SALSA mix P347 Hemochromatosis Page 4 of 7

5 Table 2c. TFR2 gene TFR2 NM_ next start codon (ex 1) L GGACACAAGCAT-GGAGCGGCTTTG 0.6 kb L GCCAGCCTTCCT-ACTGGGCTACGT 7.4 kb L b CGTGTGGACCGA-CACGCACTACGT 1.3 kb L AGGAGTGCTCAT-ATACCCAGAGCC 2.9 kb L nt after ex 10 TGAGCAACGGTA-AGGTCAGGGCCA 1.5 kb L CTCTCTATGAAC-AGGTGGTGTTCA 0.2 kb L reverse GGACTCCCACAA-AGGCCGTGAAGG 6.8 kb L TCCTCGCTTGAA-TGATTCAGGGTC stop codon (ex 18) The NM_ sequence represents transcript variant 1 and is a reference standard in the NCBI RefSeqGene project. Table 2d. HFE2 gene HFE2 NM_ next start codon (ex 2) L TGGAGAATTGGA-TAGCAGAGTAAT 1.3 kb L CTTCCGGTCAAA-ATTCACTAGGTA 0.6 kb L b CTCCGCTGCAAT-GCTGAGTACGTA No 4 stop codon (ex 4) The NM_ sequence represents transcript variant a and is a reference standard in the NCBI RefSeqGene project. Table 2e. HAMP gene HAMP NM_ next start codon (ex 1) 355 Ж SP ; CCAGAGCAAGCT-27nt spanning oligo 1 L AGACGGCACGAT 0.1 kb 436 Ж SP ; CAGTGGCTCTGT-27nt spanning oligo 1 L nt after ex 1 -GCCTGGGTCCTT 2.2 kb 250 Ж SP ; AACCCCAGGACA-24nt spanning oligo 2 L TGGTGAGCGCAA 0.2 kb L / G71D WT TTTCTGCTGCGG-CTGCTGTCATCG stop codon (ex 3) Ж This consists of three parts and has two ligation sites. Wild type sequence detected. The presence of the G71D mutation will result in a decreased signal. The NM_ sequence is a reference standard in the NCBI RefSeqGene project. Note: numbering might be different as compared to literature! Complete sequences are available on request: info@mlpa.com. Please notify us of any mistakes: info@mlpa.com. SALSA mix P347 Hemochromatosis Page 5 of 7

6 mix P347-A2 Hemochromatosis sample pictures D ye S ign al Size Figure 1. Capillary electrophoresis pattern from a sample of approximately 50 ng human male control DNA analysed with mix P347-A2 Hemochromatosis (lot A2-0213) D ye S ign al Size Figure 2. Capillary electrophoresis pattern of a male patient sample containing a heterozygous C282Y mutation, analysed with mix P347-A2 Hemochromatosis mix (lot A2-0213). The location of the C282Y specific is indicated. SALSA mix P347 Hemochromatosis Page 6 of 7

7 D ye S ign al Size Figure 3. Capillary electrophoresis pattern of a female patient sample containing a homozygous C282Y mutation, analysed with mix P347-A2 Hemochromatosis mix (lot A2-0213). The location of the C282Y specific is indicated. Implemented Changes compared to the previous product description version(s). Version 07 (49) - Figure(s) based on the use of old MLPA buffer (replaced in December 2012) removed. Version 06 (49) - Product description adapted to a new product version (version number changed, lot number added, small changes in Table 1 and Table 2, new picture included). Version 05 (48) - Figures 3 and 4 were replaced with the correct pictures of patient samples showing the C282Y mutation. - Arrows indicating C282Y mutation have been corrected. Version 04 (48) - Electropherogram pictures using the new MLPA buffer (introduced in December 2012) added. Version 03 (47) - New sample pictures of patient samples showing the C282Y mutation included. - Information about NM_ sequences added under Table 2. Version 02 (46) - Warning added for the 292 nt, this detects the wild-type sequence of the HAMP G71D mutation. Version 01 (45) - Not applicable, new document. SALSA mix P347 Hemochromatosis Page 7 of 7

MRC-Holland MLPA. Description version 05; 31 August 2017

MRC-Holland MLPA. Description version 05; 31 August 2017 mix P318-A2 Hirschsprung-2 Lot A2-0614. Compared to version A1 (lot A1-1009), the control fragments have been changed (QDX2) and some lengths have been adjusted. Hirschsprung disease is the main cause

More information

SALSA MLPA probemix P453-A1 GAA Lot A

SALSA MLPA probemix P453-A1 GAA Lot A SALSA MLPA probemix P453-A1 GAA Lot A1-0514. The GAA gene (Glucosidase, alpha; acid) encodes the enzyme acid alpha-glycosidase (or acid maltase), which is active in lysosomes where the digestive enzyme

More information

MRC-Holland MLPA. Description version 05; 16 March 2018

MRC-Holland MLPA. Description version 05; 16 March 2018 SALSA MLPA probemix P453-A2 GAA Lot A2-0617. As compared to previous version A1 (lot A1-0514), one reference probe has been removed and one has been replaced. The GAA gene encodes the enzyme acid alpha-glycosidase

More information

SALSA MLPA probemix P463-A1 MRKH Lot A1-0716

SALSA MLPA probemix P463-A1 MRKH Lot A1-0716 mix P463-A1 MRKH Lot A1-0716 Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) is characterised by normal physical development of the secondary sexual characteristics and a normal female 46,XX karyotype but

More information

SALSA MLPA probemix P367-A2 BEST1-PRPH2

SALSA MLPA probemix P367-A2 BEST1-PRPH2 SALSA MLPA probemix P367-A2 BEST1-PRPH2 Lot A2-0513. As compared to the previous version A1 (lot A1-0809), two reference probes have been replaced and the control fragments have been adjusted (QDX2). Please

More information

In addition, 12 reference probes are included in this probemix, detecting several different autosomal chromosomal locations.

In addition, 12 reference probes are included in this probemix, detecting several different autosomal chromosomal locations. SALSA MLPA probemix P350-B1 CLCN1-KCNJ2 Lot B1-0711: As compared to the previous version A1 (lot A1-1109), two CLCN1 probes, one KCNJ2 probe and four reference probes have been replaced, one new KCNJ2

More information

MRC-Holland MLPA. Description version 06; 28 September 2017

MRC-Holland MLPA. Description version 06; 28 September 2017 mix P318-B1 Hirschsprung-2 Lot B1-0817. As compared to version A2 (lot A2-0614), nine reference s have been added and the length of several s has been adjusted. Hirschsprung disease (MIM142623) is the

More information

MRC-Holland MLPA. Description version 08;

MRC-Holland MLPA. Description version 08; SALSA MLPA mix P075-B1 TCF4-FOXG1 Lot B1-0614: As compared to version A1 (lot A1-0510), seven target specific s have been replaced and eight new s have been included. Furthermore, three reference s have

More information

MRC-Holland MLPA. Description version 11; 20 November 2015

MRC-Holland MLPA. Description version 11; 20 November 2015 SALSA MLPA probemix P310-B2 TCOF1 Lot B2-0614, B2-0511. As compared to version B1 (lot B1-0110), the 88 and 96 nt control fragments have been replaced (QDX2). Treacher Collins-Franceschetti 1 syndrome

More information

MRC-Holland MLPA. Description version 10; 03 August 2015

MRC-Holland MLPA. Description version 10; 03 August 2015 SALSA MLPA probemix P278-C1 PCCA Lot C1-0712. As compared to lot B2-0409, five reference probes have been replaced and two reference probes have been removed. Also, QDX2 control fragments have been added

More information

MRC-Holland MLPA. Description version 10; 16 March 2017

MRC-Holland MLPA. Description version 10; 16 March 2017 SALSA MLPA probemix P199-B2 HEXA Lot B2-0115. As compared to version B1 (lot B1-0410), two reference probes have been replaced and the control fragments have been adjusted (QDX2). Tay-Sachs disease is

More information

Furthermore, 8 reference probes are included in this probemix, detecting several different autosomal chromosomal locations.

Furthermore, 8 reference probes are included in this probemix, detecting several different autosomal chromosomal locations. SALSA MLPA mix P328-A2 EYS Lot A2-0217. As compared to version A1, two reference s have been replaced and one length has been adjusted. Retinitis Pigmentosa-25 (RP25) is characterised by progressive peripheral

More information

MRC-Holland MLPA. Description version 07;

MRC-Holland MLPA. Description version 07; SALSA MLPA probemix P267-A3 Dandy-Walker Malformation Lot A3-0813. As compared to the previous lot A2-0209, two reference probes have been replaced and one added. Also, the control fragments have been

More information

SALSA MLPA probemix P398-A1 CASK Lot A1-1014, Lot A

SALSA MLPA probemix P398-A1 CASK Lot A1-1014, Lot A SALSA MLPA probemix P398-A1 CASK Lot A1-1014, Lot A1-0611. The CASK gene encodes a calcium/calmodulin-dependent serine protein kinase that is a member of the membrane-associated guanylate kinase (MAGUK)

More information

MRC-Holland MLPA. Description version 10; 17 November 2016

MRC-Holland MLPA. Description version 10; 17 November 2016 SALSA MLPA probemix P058-A3 IGHMBP2 Lot A3-1016. As compared to the previous lot A2-0412, one reference probe has been removed and one replaced. In addition, one probe length has been adjusted. Spinal

More information

SALSA MLPA probemix P267-A3 Dandy-Walker Malformation Lot A3-0317, Lot A

SALSA MLPA probemix P267-A3 Dandy-Walker Malformation Lot A3-0317, Lot A SALSA MLPA probemix P267-A3 Dandy-Walker Malformation Lot A3-0317, Lot A3-0813. Dandy-Walker malformation (DWM) is characterised by cerebellar hypoplasia and upward rotation of the cerebellar vermis, cystic

More information

SALSA MLPA probemix P207-C3 F9 Lot C As compared to version C three reference probes have been removed.

SALSA MLPA probemix P207-C3 F9 Lot C As compared to version C three reference probes have been removed. SALSA MLPA probemix P207-C3 F9 Lot C3-1214. As compared to version C2-0312 three reference probes have been removed. Factor IX deficiency (also called Hemophilia B or Christmas disease) is characterized

More information

MRC-Holland MLPA. Related SALSA MLPA probemixes P054 FOXL2-TWIST1: Contains probes for the GPR143 gene on Xp22.2.

MRC-Holland MLPA. Related SALSA MLPA probemixes P054 FOXL2-TWIST1: Contains probes for the GPR143 gene on Xp22.2. SALSA MLPA probemix P160-C1 STS Lot C1-0816. As compared to version B1 (lot B1-0313), two STS probes have been added and one flanking probe and the Y-fragment on 118 nt have been removed. Two STS probes,

More information

SALSA MLPA probemix P155-D2 Ehlers-Danlos syndrome III & IV

SALSA MLPA probemix P155-D2 Ehlers-Danlos syndrome III & IV SALSA MLPA probemix P155-D2 Ehlers-Danlos syndrome III & IV Lot D2-0617. As compared to previous version D1 (lot D1-1114), one reference probe has been replaced. The Ehlers-Danlos syndrome type III (EDS

More information

MRC-Holland MLPA. Description version 31;

MRC-Holland MLPA. Description version 31; SALSA MLPA probemix P002-C2 BRCA1 Lot C2-0313, C2-0113, C2-0811, C2-0111. As compared to the previous C1 version (lot 1209 & 0409), the 88 and 96 nt DNA Denaturation control fragments have been replaced

More information

MRC-Holland MLPA. Description version 07; 23 Feb 2015

MRC-Holland MLPA. Description version 07; 23 Feb 2015 SALSA MLPA probemix P326-A2 LARGE, FKTN, POMT2 Lot A2-0513. Compared to previous lot (A1-0709), one reference probe has been replaced and the control fragments have been adjusted (QDX2). Walker-Warburg

More information

SALSA MLPA probemix P155-D1 Ehlers-Danlos syndrome III & IV

SALSA MLPA probemix P155-D1 Ehlers-Danlos syndrome III & IV SALSA MLPA probemix P155-D1 Ehlers-Danlos syndrome III & IV Lot D1-1114. As compared to previous version (lot C1-0811), one reference probe and one COL3A1 target probe have been removed, and the length

More information

MRC-Holland MLPA. Description version 08; 02 June 2017

MRC-Holland MLPA. Description version 08; 02 June 2017 SALSA MLPA probemix P367-A2 BEST1-PRPH2 Lot A2-0616, A2-0513. As compared to version A1 (lot A1-0809), two reference probes have been replaced and the control fragments have been adjusted (QDX2). Please

More information

SALSA MLPA probemix P350-B2 CLCN1-KCNJ2 Lot B As compared to version B1-0711, one reference probe has been removed.

SALSA MLPA probemix P350-B2 CLCN1-KCNJ2 Lot B As compared to version B1-0711, one reference probe has been removed. SALSA MLPA probemix P350-B2 CLCN1-KCNJ2 Lot B2-1015. As compared to version B1-0711, one reference probe has been removed. Myotonia congenita is characterised by muscle stiffness and delayed relaxation

More information

MRC-Holland MLPA. Description version 12; 27 November 2015

MRC-Holland MLPA. Description version 12; 27 November 2015 SALSA MLPA probemix P079-A3 OTC Lot A3-1015. As compared to previous version (lot A2-0211), 5 reference probes have been replaced. Also, 8 reference probes and the TSPAN7 flanking probe have been removed.

More information

SALSA MLPA probemix P074-A3 Androgen Receptor (AR) Lot A Compared to previous lot A2-0712, three reference probes have been replaced.

SALSA MLPA probemix P074-A3 Androgen Receptor (AR) Lot A Compared to previous lot A2-0712, three reference probes have been replaced. SALSA MLPA probemix P074-A3 Androgen Receptor (AR) Lot A3-0814. Compared to previous lot A2-0712, three reference probes have been replaced. The androgen insensitivity syndrome (AIS), formerly known as

More information

MRC-Holland MLPA. Description version 05;

MRC-Holland MLPA. Description version 05; MLPA Probemix P235-B2 Retinitis Pigmentosa Lot B2-1013: As compared to the previous version B1 (lot B1-0808), two reference probes have been replaced and one added; in addition, the control fragments have

More information

SALSA MLPA probemix P176-C2 CAPN3 Lot C2-0813: Compared to previous lot C1-0213, one reference probe has been removed.

SALSA MLPA probemix P176-C2 CAPN3 Lot C2-0813: Compared to previous lot C1-0213, one reference probe has been removed. SALSA MLPA probemix P176-C2 CAPN3 Lot C2-0813: Compared to previous lot C1-0213, one reference probe has been removed. Limb-girdle muscular dystrophies (LGMD) are a group of phenotypically and genotypically

More information

SALSA MLPA probemix P083-C2 CDH1 Lot C & lot C As compared to previous C version, five reference probes have been replaced.

SALSA MLPA probemix P083-C2 CDH1 Lot C & lot C As compared to previous C version, five reference probes have been replaced. SALSA MLPA probemix P083-C2 CDH1 Lot C2-0215 & lot C2-1113. As compared to previous C1-0211 version, five reference probes have been replaced. Germline mutations in the CDH1 gene have been reported in

More information

The SCN5A protein is found primarily in cardiac muscle and mediates the voltage-dependent sodium ion permeability of excitable membranes.

The SCN5A protein is found primarily in cardiac muscle and mediates the voltage-dependent sodium ion permeability of excitable membranes. SALSA MLPA probemix P108-B3 SCN5A Lot B3-0916. As compared to the previous lot (B2-0312), two reference probes have been replaced and two probe lengths have been adjusted. The Brugada syndrome-1 and long

More information

MRC-Holland MLPA. Description version 09; 31 March 2016

MRC-Holland MLPA. Description version 09; 31 March 2016 SALSA MLPA probemix P071-B1 LMNB1-PLP1-NOTCH3 Lot B1-0316. Compared to previous lot A2-0112, three reference probes have been replaced, and the NOTCH3 exon 22 probe has been removed. Leukodystrophies are

More information

MRC-Holland MLPA. Description version 11; 07 December 2015

MRC-Holland MLPA. Description version 11; 07 December 2015 SALSA MLPA probemix P049-C1 SLC6A8 ABCD1 Lot C1-1015, C1-1111. Compared to the previous version (B2-0511), one probe for both GDI1 and FLNA have been replaced and one probe for exon 6 of ABCD1 has been

More information

In addition, 10 reference probes are included in this probemix, detecting several different autosomal chromosomal locations.

In addition, 10 reference probes are included in this probemix, detecting several different autosomal chromosomal locations. SALSA MLPA probemix P179-B1 Limb Malformations-1 Lot B1-1014, B1-0611. As compared to the previous lot A2 (lot A2-0311), one GLI3 and three ROR2 probes have been replaced. Four extra GLI3 probes and one

More information

MRC-Holland MLPA. Description version 11; 7 September 2017

MRC-Holland MLPA. Description version 11; 7 September 2017 SALSA MLPA mix P268-A2 DYSF Lot A2-1115, A2-0312. Compared to previous version A1-0608, two reference s have been replaced and one reference has been added. In addition, the control fragments have been

More information

MRC-Holland MLPA. Description version 17;

MRC-Holland MLPA. Description version 17; SALSA MLPA probemix P080-C1 CRANIOFACIAL Lot C1-1213. As compared to version B1 (lot B1-0710, B1-0909) one of two ALX4 exon 2 probes is removed, the two FGFR2 and FGFR3 probes at the location of the APERT

More information

In addition, 9 reference probes are included in the P116 probemix, detecting several autosomal locations.

In addition, 9 reference probes are included in the P116 probemix, detecting several autosomal locations. mix P116-B1 SGC Lot B1-0115, B1-0511. As compared to version A1 (lot A1-0708), one extra probe each for SGCB, SGCD and FKRP have been included. Five reference probes and the control fragments have been

More information

MRC-Holland MLPA. Description version 11; 01 September 2017

MRC-Holland MLPA. Description version 11; 01 September 2017 SALSA MLPA probemix P262-B1 GHI Lot B1-0717. As compared to version A2 (lot A2-1114), all reference probes have been replaced and five reference probes have been added. In addition, one STAT5B probe has

More information

MRC-Holland MLPA. Description version 23;

MRC-Holland MLPA. Description version 23; SALSA MLPA probemix P087-C1 BRCA1 Lot C1-0114 & C1-0813: As compared to previous version B1, three reference probes have been replaced and three extra reference probes have been included. The 88 and 96

More information

MRC-Holland MLPA. Description version 16; 29 May 2017

MRC-Holland MLPA. Description version 16; 29 May 2017 SALSA MLPA probemix P029-C1 Williams-Beuren Syndrome Lot C1-0517. As compared to version B1 (lot B1-0315, B1-1211), two target probes have been removed, three reference probes have been replaced and three

More information

MRC-Holland MLPA. Description version 09; 28 April 2016

MRC-Holland MLPA. Description version 09; 28 April 2016 SALSA MLPA probemix P244-C1 AIP-MEN1-CDKN1B Lot C1-0815, C1-1112. Note that the name of the product has been changed to P244 AIP-MEN1-CDKN1B (from lot C1-1112 onwards). Multiple endocrine neoplasia (MEN)

More information

In addition, ten reference probes are included in this probemix, detecting several different autosomal chromosomal locations.

In addition, ten reference probes are included in this probemix, detecting several different autosomal chromosomal locations. SALSA MLPA probemix P186-C2 PAX3 MITF SOX10 Lot C2-0916: As compared to version C1 (lot C1-0212), one reference probe has been replaced and several probe lengths have been adjusted. Several types of Waardenburg

More information

MRC-Holland MLPA. Description version 12; 16 March 2015

MRC-Holland MLPA. Description version 12; 16 March 2015 P128-C1 Cytochrome P450 mix Lot C1-1014. As compared to version B2 (lot B2-0811), nine reference s have been replaced and one CYP2D6 has been removed. This SALSA mix is for basic research and intended

More information

SALSA MLPA probemix P200-A1 Human DNA Reference-1 Lot A1-1113, Lot A1-0410, A1-0209, A1-0408

SALSA MLPA probemix P200-A1 Human DNA Reference-1 Lot A1-1113, Lot A1-0410, A1-0209, A1-0408 SALSA MLPA probemix P200-A1 Human DNA Reference-1 Lot A1-1113, Lot A1-0410, A1-0209, A1-0408 The P200-A1 Human DNA Reference-1 probemix contains reference probes and control fragments specific for unique

More information

SALSA MLPA probemix P338-B1 GBA Lot B

SALSA MLPA probemix P338-B1 GBA Lot B SALSA MLPA probemix P338-B1 GBA Lot B1-0716. This SALSA probemix is for basic research and intended for experienced MLPA users only! This probemix enables you to quantify genes or chromosomal regions in

More information

Related SALSA MLPA kits P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, BRCA1&2, PTEN, TP53

Related SALSA MLPA kits P190 CHEK2: Breast cancer susceptibility, genes included: CHEK2, ATM, BRCA1&2, PTEN, TP53 SALSA MLPA KIT P056-A2 TP53 Lot 1108. One reference probe has been replaced, five probes have a small change in length (but no change in sequence detected) and four extra control fragments at 88-96-100-105

More information

SALSA MLPA probemix P466-A1 CDC73 Lot A

SALSA MLPA probemix P466-A1 CDC73 Lot A SALSA MLPA probemix P466-A1 CDC73 Lot A1-0415. Germ-line inactivating point mutations and deletions of CDC73 gene (also known as HRTP2) underlie hyperparathyroidism-jaw tumour syndrome (HPT-JT) (OMIM:

More information

MRC-Holland MLPA. Description version 14;

MRC-Holland MLPA. Description version 14; SALSA MLPA KIT P018-E1 SHOX Lot 1009. As compared to version D1 (lots 0409, 0408), six probes located on chromosome X and six reference probes have been replaced. Léri-Weill Dyschondrosteosis (LWD) is

More information

SALSA MLPA kit A071 - A078 DMD Lot 0606

SALSA MLPA kit A071 - A078 DMD Lot 0606 kit A071 - A078 DMD Lot 0606 Please note: This SALSA kit has been developed for the low-resolution detection of DMD (partial) deletions with an agarose gel electrophoresis or Agilent microfluidics. kit

More information

MRC-Holland MLPA. Description version 15; 23 July 2015

MRC-Holland MLPA. Description version 15; 23 July 2015 SALSA MLPA probemix P125-B1 Mitochondria Lot B1-0312 B1-0609. Compared to the previous version of this product (lots A1-0606, A1-1105), four probes have been replaced and six extra mitochondrial probes

More information

MRC-Holland MLPA. Description version 05; 14 March 2016

MRC-Holland MLPA. Description version 05; 14 March 2016 SALSA MLPA probemix P419-A2 CDKN2A/2B-CDK4 Melanoma Lot A2-0215. As compared to previous lot A1-0412, several probes have a small change in length, but no change in sequence detected. Malignant melanoma

More information

Product Description SALSA MLPA Probemix P438-D2 HLA

Product Description SALSA MLPA Probemix P438-D2 HLA Product Description SALSA Probemix P438-D2 HLA To be used with the MLPA General Protocol. Version D2. Catalogue numbers: P438-025R: SALSA MLPA Probemix P438 HLA, 25 reactions. P438-050R: SALSA MLPA Probemix

More information

SALSA MLPA KIT P029-A1

SALSA MLPA KIT P029-A1 SALSA MLPA KIT P029-A1 Williams-Beuren Syndrome Lot 1207: As compared to the previous lots 0403 and 0606, two DNA Denaturation control fragments (Dfragments) at 88 and 96 nt have been added. Small changes

More information

SALSA MLPA probemix P125-B1 Mitochondria Lot B1-0216, B1-0312, B

SALSA MLPA probemix P125-B1 Mitochondria Lot B1-0216, B1-0312, B SALSA MLPA probemix P125-B1 Mitochondria Lot B1-0216, B1-0312, B1-0609. Mitochondrial DNA (mtdna) differs from nuclear DNA in several ways. The complete mitochondrial genome is circular and only 16,569

More information

MRC-Holland MLPA. Related SALSA MLPA probemix P102 HBB: Contains probes for the HBB gene

MRC-Holland MLPA. Related SALSA MLPA probemix P102 HBB: Contains probes for the HBB gene SALSA MLPA probemix P140-B4 HBA Lot B4-0413, B4-1212 & B4-0312: Compared to the previous version B3 (lot B3-0510), the 88 and 96 nt control fragments have been replaced (QDX2). The human alpha globin gene

More information

MRC-Holland MLPA. Related SALSA MLPA probemixes P140 HBA: Contains probes for the HBA gene region. Description version 20;

MRC-Holland MLPA. Related SALSA MLPA probemixes P140 HBA: Contains probes for the HBA gene region. Description version 20; SALSA MLPA probemix P102-B2 HBB Lot B2-0212: As compared to the previous B1 version (lots B1-0410, B1-1108, B1-0508), the 88 and 96 nt control fragments have been replaced. BETA-ZERO-THALASSEMIA is caused

More information

MRC-Holland MLPA. Related SALSA MLPA probemixes P102 HBB: Contains probes for the HBB gene. Description version 30;

MRC-Holland MLPA. Related SALSA MLPA probemixes P102 HBB: Contains probes for the HBB gene. Description version 30; SALSA MLPA probemix P140-B4 HBA Lot B4-1212 & B4-0312: Compared to the previous version B3 (lot B3-0510), the 88 and 96 nt control fragments have been replaced (QDX2). The human alpha globin gene cluster

More information

SALSA MLPA KIT P018-D1 SHOX Lot 0409, As compared to version C, several changes have been made as indicated on page 3.

SALSA MLPA KIT P018-D1 SHOX Lot 0409, As compared to version C, several changes have been made as indicated on page 3. SALSA MLPA KIT P018-D1 SHOX Lot 0409, 0408. As compared to version C, several changes have been made as indicated on page 3. Mutations or deletions of the SHOX gene, located in the PAR1 region, are involved

More information

MRC-Holland MLPA. Description version 14;

MRC-Holland MLPA. Description version 14; SALSA MS-MLPA KIT ME011-B1 Mismatch Repair genes (MMR) Lot 1009. As compared to version A1, two probes have been replaced and three extra probes have been added. One MSH3 probe is replaced and one removed.

More information

MRC-Holland MLPA. Description version 30;

MRC-Holland MLPA. Description version 30; SALSA MLPA probemix P021-A2 SMA Lot A2-0511: As compared to the previous version A1 (lots A1-0910, A1-1209, A1-0809, A1-1208, A1-0808, A1-0208 & A1-0807), two control fragments (88 and 96 nt) have been

More information

MRC-Holland MLPA. Description version 10; 8 March 2018

MRC-Holland MLPA. Description version 10; 8 March 2018 mix P264-C1 Human Telomere-9 Lot C1-0517. As compared to version B1, one in the 3q region and two s in the 4q region have been replaced. Furthermore, 32 s have been changed in length, but not in sequence

More information

Product Description SALSA MLPA Probemix P099-C3 GCH1-TH-SGCE To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P099-C3 GCH1-TH-SGCE To be used with the MLPA General Protocol. Product Description SALSA Probemix P099-C3 GCH1-TH-SGCE To be used with the MLPA General Protocol. Version C3. As compared to version C2, one reference probe has been replaced and one probe has a small

More information

MRC-Holland MLPA. Description version 35b; 11 August 2017

MRC-Holland MLPA. Description version 35b; 11 August 2017 SALSA MLPA probemix P021-A2 SMA Lot A2-0316, Lot A2-0415, Lot A2-0613, Lot A2-0511: As compared to the previous version A1 (lots A1-0910, A1-1209, A1-0809, A1-1208, A1-0808, A1-0208 & A1-0807), two control

More information

MRC-Holland MLPA. Description version 07;

MRC-Holland MLPA. Description version 07; mix P264-B1 Human Telomere-9 Lot 0511. As compared to version A1 several new s have been added and the 88 and 96 nt control fragments have been replaced (QDX2). This mix can also be bought as part of the

More information

Product Description SALSA MLPA probemix P128-D1 CYP450 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P128-D1 CYP450 To be used with the MLPA General Protocol. Product Description SALSA mix P128-D1 CYP450 To be used with the MLPA General Protocol. Version D1. As compared to version C1, one for CYP2B6 and one for CYP3A5 were removed, in addition one reference

More information

Product Description SALSA MLPA probemix P090-B1 BRCA2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P090-B1 BRCA2 To be used with the MLPA General Protocol. Product Description SALSA probemix P090-B1 BRCA2 To be used with the MLPA General Protocol. Version B1. As compared to version A4, the probes for the BRCA2 upstream region and exons 8, 11, 12, 19 and 27

More information

Product Description SALSA MLPA probemix P073-A1 IKBKG To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P073-A1 IKBKG To be used with the MLPA General Protocol. Version A1, lot A1-1015. Product Description SALSA probemix P073-A1 IKBKG To be used with the MLPA General Protocol. Catalogue numbers: P073-025R: SALSA probemix P073 IKBKG, 25 reactions. P073-050R: SALSA

More information

Product Description SALSA MLPA Probemix P378-D1 MUTYH To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P378-D1 MUTYH To be used with the MLPA General Protocol. Product Description SALSA Probemix P378-D1 MUTYH To be used with the MLPA General Protocol. Version D1. As compared to version C1, one new reference probe has been added and 11 have been replaced; MUTYH

More information

Certificate of Analysis SALSA Binning DNA SD067

Certificate of Analysis SALSA Binning DNA SD067 Catalogue # SD067 Product name SALSA Binning DNA SD067 S01-0116 SALSA Binning DNA SD067 6 reactions. Shipping conditions Dry ice or cooling elements. Store upon arrival between -25 C and -15 C. Expiration

More information

Certificate of Analysis SALSA MLPA probemix P008 PMS2

Certificate of Analysis SALSA MLPA probemix P008 PMS2 COA Version 01; Issued 05-05-2014 Certificate of Analysis SALSA probemix P008 PMS2 Catalogue # P008-025R, P008-50R, P008-100R Product name Probemix P008 PMS2 C1-0214 25, 50 or 100 reactions. Shipping conditions

More information

Certificate of Analysis SALSA Binning DNA SD022

Certificate of Analysis SALSA Binning DNA SD022 Catalogue # SD022 Product name SALSA Binning DNA SD022 S01-0717 SALSA Binning DNA SD022 6 reactions. Shipping conditions Dry ice or cooling elements. Store upon arrival between -25 C and -15 C. Expiration

More information

Product Description SALSA MLPA Probemix P034-B2 DMD-1 & P035-B1 DMD-2 To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P034-B2 DMD-1 & P035-B1 DMD-2 To be used with the MLPA General Protocol. Product Description SALSA Probemix P034-B2 DMD-1 & P035-B1 DMD-2 To be used with the MLPA General Protocol. P034 version B2. As compared to version B1, two probes have a very small change in length, but

More information

SALSA MLPA probemix P277-B2 Human Telomere-10 Lot B As compared to version B1-1210, the control fragments have been replaced (QDX2).

SALSA MLPA probemix P277-B2 Human Telomere-10 Lot B As compared to version B1-1210, the control fragments have been replaced (QDX2). SALSA MLPA probemix P277-B2 Human Telomere-10 Lot B2-1115. As compared to version B1-1210, the control fragments have been replaced (QDX2). This P277-B2 probemix can be used to confirm and further characterise

More information

Product Description SALSA MLPA probemix P091-D1 CFTR To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P091-D1 CFTR To be used with the MLPA General Protocol. Product Description SALSA probemix P091-D1 CFTR To be used with the MLPA General Protocol. Version D1. As compared to version C1, 3 CFTR and 4 reference probes have been replaced. In addition, the 88 and

More information

Product Description SALSA MS-MLPA Probemix ME030-C3 BWS/RSS To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME030-C3 BWS/RSS To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME030-C3 BWS/RSS To be used with the MS-MLPA General Protocol. Version C3. For complete product history see page 9. Catalogue numbers: ME030-025R: SALSA MS-MLPA ME030

More information

Product Description SALSA MLPA Probemix P050-C1 CAH To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P050-C1 CAH To be used with the MLPA General Protocol. Product Description SALSA Probemix P050-C1 CAH To be used with the MLPA General Protocol. Version C1. For complete product history see page 10. Catalogue numbers: P050-025R: SALSA MLPA Probemix P050 CAH,

More information

Product Description SALSA MLPA probemix P033-B4 CMT1 To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P033-B4 CMT1 To be used with the MLPA General Protocol. Product Description SALSA probemix P033-B4 CMT1 To be used with the MLPA General Protocol. Version B4. As compared to version B3, three reference probes have been replaced. For complete product history

More information

Product Description SALSA MLPA probemix P065-C1 & P066-C1 Marfan Syndrome To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P065-C1 & P066-C1 Marfan Syndrome To be used with the MLPA General Protocol. Product Description SALSA probemix P065-C1 & P066-C1 Marfan Syndrome To be used with the MLPA General Protocol. P065 Version C1. Compared to version B1, one FBN1 probe and three reference probes were replaced.

More information

Certificate of Analysis SALSA MLPA probemix P140 HBA

Certificate of Analysis SALSA MLPA probemix P140 HBA COA Version 01; Issued 01-03-2014 Certificate of Analysis SALSA probemix P140 HBA Catalogue # P140-025R, P140-50R, P140-100R Product name Probemix P140 HBA C1-0114 25, 50 or 100 reactions. Shipping conditions

More information

Product Description SALSA MLPA probemix P060-B2 SMA To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P060-B2 SMA To be used with the MLPA General Protocol. Product Description SALSA probemix P060-B2 SMA To be used with the MLPA General Protocol. Version B2. As compared to version B1, the 88 and 96 nt DNA denaturation control fragments have been replaced (QDX2).

More information

Product Description SALSA MS-MLPA Probemix ME042-C1 CIMP To be used with the MS-MLPA General Protocol.

Product Description SALSA MS-MLPA Probemix ME042-C1 CIMP To be used with the MS-MLPA General Protocol. Product Description SALSA MS- Probemix ME042-C1 CIMP To be used with the MS-MLPA General Protocol. Version C1. As compared to version B2, the length of the BRAF V600E mutation-specific probe has been changed

More information

Product Description SALSA MLPA Probemix P226-D1 SDH To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P226-D1 SDH To be used with the MLPA General Protocol. Product Description SALSA Probemix P226-D1 SDH To be used with the MLPA General Protocol. Version D1. As compared to version C1, one target for SDHB exon 1, one target for SDHC exon 4 and one target for

More information

Product Description SALSA MLPA probemix P077-B1 BRCA2 Confirmation To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P077-B1 BRCA2 Confirmation To be used with the MLPA General Protocol. Product Description SALSA probemix P077-B1 BRCA2 Confirmation To be used with the MLPA General Protocol. Version B1. As compared to the A3 version, 14 target probes and 6 reference probes have been replaced

More information

Multiplex Ligation-dependent Probe Amplification (MLPA ) General Protocol

Multiplex Ligation-dependent Probe Amplification (MLPA ) General Protocol DNA protocol version MDP-v002; last update 23-01-2012 Multiplex Ligation-dependent Probe Amplification ( ) General Protocol Instructions for use General MLPA protocol for the detection and quantification

More information

Product Description SALSA MLPA probemix P140-C1 HBA To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P140-C1 HBA To be used with the MLPA General Protocol. Product Description SALSA probemix P140-C1 HBA To be used with the MLPA General Protocol. Version C1. Released June 2014. For complete product history see page 17. Catalogue numbers: P140-025R: SALSA MLPA

More information

MLPA General Protocol

MLPA General Protocol MLPA General Protocol Instructions For Use General MLPA protocol for the detection and quantification of nucleic acid sequences. To be used in combination with the appropriate MLPA probemix-specific product

More information

Genomic DNA was extracted from 3 to 5 ml of blood collected in EDTA blood collection tubes

Genomic DNA was extracted from 3 to 5 ml of blood collected in EDTA blood collection tubes Supplementary information Methods DNA and RNA extraction Genomic DNA was extracted from to ml of blood collected in EDTA blood collection tubes using the Gentra Puregene Blood kit (Qiagen, California,

More information

MLPA assays on the SeqStudio Genetic Analyzer

MLPA assays on the SeqStudio Genetic Analyzer APPLICATION NOTE MLPA assays on the SeqStudio Genetic Analyzer SeqStudio Genetic Analyzer In this application note, we demonstrate that: The new Applied Biosystems SeqStudio Genetic Analyzer generates

More information

MS-MLPA General Protocol

MS-MLPA General Protocol MS-MLPA General Protocol Instructions For Use MS-MLPA (Methylation-Specific Multiplex Ligation-dependent Probe Amplification) General Protocol for the detection and quantification of DNA sequences and

More information

Han Chinese patients with dopa-responsive dystonia exhibit a low frequency of exonic deletion in the GCH1 gene

Han Chinese patients with dopa-responsive dystonia exhibit a low frequency of exonic deletion in the GCH1 gene Han Chinese patients with dopa-responsive dystonia exhibit a low frequency of exonic deletion in the GCH1 gene W.T. Shi*, C.Y. Cai*, M.S. Li, C. Ling and W.D. Li Research Center of Basic Medical Sciences,

More information

Certification in Clinical Molecular Genetics and Genomics Logbook Guidelines for 2019 Examination

Certification in Clinical Molecular Genetics and Genomics Logbook Guidelines for 2019 Examination Certification in Clinical Molecular Genetics and Genomics Logbook Guidelines for 2019 Examination Purpose: The purpose of the logbook is to document that the applicant has had direct and meaningful involvement

More information

AMERICAN BOARD OF MEDICAL GENETICS

AMERICAN BOARD OF MEDICAL GENETICS AMERICAN BOARD OF MEDICAL GENETICS Logbook Guidelines for Certification in Clinical Molecular Genetics for the 2015 Examination Purpose: The purpose of the logbook is to document that the applicant has

More information

Product Description SALSA MLPA probemix P018-G1 SHOX To be used with the MLPA General Protocol.

Product Description SALSA MLPA probemix P018-G1 SHOX To be used with the MLPA General Protocol. Product Description SALSA probemix P018-G1 SHOX To be used with the MLPA General Protocol. Version G1. One SHOX area probe has been replaced (CNE4) and four new probes have been included for the upstream

More information

Product Description SALSA MLPA Probemix P021-B1 SMA To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P021-B1 SMA To be used with the MLPA General Protocol. Product Description SALSA Probemix P021-B1 SMA To be used with the MLPA General Protocol. Version B1. As compared to version A2, thirteen SMN probes detecting sequences in both SMN1 and SMN2 have been

More information

Product Description SALSA MLPA Probemix P102-D1 HBB To be used with the MLPA General Protocol.

Product Description SALSA MLPA Probemix P102-D1 HBB To be used with the MLPA General Protocol. Product Description SALSA Probemix P102-D1 HBB To be used with the MLPA General Protocol. Version D1. As compared to version C1, two target probes have been removed and three new target probes have been

More information

Single Nucleotide Variant Analysis. H3ABioNet May 14, 2014

Single Nucleotide Variant Analysis. H3ABioNet May 14, 2014 Single Nucleotide Variant Analysis H3ABioNet May 14, 2014 Outline What are SNPs and SNVs? How do we identify them? How do we call them? SAMTools GATK VCF File Format Let s call variants! Single Nucleotide

More information

GENOTYPING BY PCR PROTOCOL FORM MUTANT MOUSE REGIONAL RESOURCE CENTER North America, International

GENOTYPING BY PCR PROTOCOL FORM MUTANT MOUSE REGIONAL RESOURCE CENTER North America, International Please provide the following information required for genetic analysis of your mutant mice. Please fill in form electronically by tabbing through the text fields. The first 2 pages are protected with gray

More information

Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination

Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination Purpose: The purpose of the logbook is to document that the applicant has had direct and meaningful involvement in

More information

American Board of Medical Genetics and Genomics

American Board of Medical Genetics and Genomics American Board of Medical Genetics and Genomics Logbook Guidelines for Certification in Laboratory Genetics and Genomics for the 2019 Examination as of 11/10/2016 Purpose: The purpose of the logbook is

More information

Genetics fundamentals and DNA toolkit. Partha Roy

Genetics fundamentals and DNA toolkit. Partha Roy Genetics fundamentals and DNA toolkit Partha Roy 1 (REVIEW of Terminologies and Concepts) Haploid organism: single copy of chromosome (ex: bacteria, yeast) Diploid organism: two copies of chromosome (paternal

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers Wataru Sakai, Elizabeth M. Swisher, Beth Y. Karlan, Mukesh K. Agarwal, Jake Higgins, Cynthia Friedman, Emily Villegas,

More information